glp-1 obesity drugs news today The Multi-Sector Impacts of GLP-1RA Commentary: New obesity drugs face

Acute water ingestion increases arterial blood pressure in hypertensive and normotensive subjects

This is also why a secretagogue approach is framed as "axis-friendly": because endogenous somatostatin is still in the loop, negative feedback is preserved, which in principle restrains the supraphysiologic IGF-1 spikes seen with exogenous GH

The TRIUMPH programme will investigate retatrutide in people with obesity and the TRANSCEND-T2D programme is investigating retatrutide in people with T2D and overweight/obesity

Rather than trial-and-error supplementation, biomarker-guided and genetically informed assessment clarifies which interventions align with your actual immune and oxidative stress profile